Table 2.

Cis-eQTL analysis results for top risk SNPs associated with prostate cancer specific survival time. Chromosome positions are given in b37.

CHR	SNP	BP	Gene	Start-End	P	Ref. allele	Risk allele	ß
10	rs35105661	69796848	SIRT1	69644427–69678147	1.30E-09	CT	C	0.053
10	rs35105661	69796848	DNAJC12	69556427–69597924	2.59E-09	CT	C	0.154
15	rs 16970844	40881268	C15orf57	40820882–40857256	6.57E-06	C	T	0.173
10	rs35105661	69796848	HERC4	69681665–69835105	9.06E-05	CT	c	0.020
2	rs73055188	201532698	AOX1	201450591–201541787	1.51 E-03	G	A	−0.143
15	rs 16970844	40881268	GCHFR	41056218–41059906	3.21 E-03	C	T	−0.099
2	rs 16834021	201540988	AOX1	201450591–201541787	3.87E-03	C	T	−0.1304
2	rs16834027	201541827	AOX1	201450591–201541787	3.87E-03	G	A	−0.1304
2	rs 16834034	201542014	AOX1	201450591–201541787	3.87E-03	T	G	−0.1304
2	rs73055201	201538788	AOX1	201450591–201541787	6.63E-03	G	A	−0.1197
1	rs2702185	183501350	NCF2	183524698–183560011	0.0153	C	T	0.102
15	rs 16970844	40881268	IVD	40697686–40728146	0.0159	C	T	−0.051
1	rs2702185	183501350	ARPC5	183592401–183604892	0.0180	C	T	−0.029
15	rs 16970844	40881268	CASC5	40886218–40956540	0.0203	C	T	0.138

Abbreviation: CHR: chromosome number; BP: chromosome coordinate of each SNP; Start-End: chromosome coordinate of each gene; P: P value; β: regression coefficient.